Introduction
Many researchers have been interested in determining the physiological impact of the use of respiratory protective devices (RPDs) in human wearers. In recent times carbon dioxide (CO 2 ) rebreathing in RPDs has been highlighted as a key concern regarding respirator use.
Rebreathing can occur if expired air, which is CO 2 rich, remains in the breathing space of the respirator after each breath. This can increase arterial CO 2 concentrations which can generate symptoms of discomfort, fatigue, dizziness, headache, shortness of breath, muscular weakness and drowsiness (Kloos and Lamonica 1966) .
It is known that dead space (respirator volume) and hypoventilation related to breathing resistance in RPDs can contribute to CO 2 rebreathing. The effects of exercise, duration of respirator use, breathing technique, individual sensitivity to CO 2 and susceptibility to claustrophobia can also influence CO 2 rebreathing (ISO/TS 16976-3: 2011).
The impact of phonic respiration, or breathing during speech, on CO 2 levels in RPDs has not previously been evaluated. Phonic respiration occurs during exhalation and as a result decreases inhalation time (ISO/TS 16976-1: 2007) . According to Boron and Boulpaep (2005) following the cessation of speech, breathing rate can increase by 25% and alveolar CO 2 (PACO 2 ) falls. Doust and Patrick (1981) proposed that hypercapnia could explain the above increase in respiration observed at the end of speech. To our knowledge no researchers have focused on the influence of speech on CO 2 concentrations in RPDs.
Therefore, the present study aimed to evaluate if speech and exercise workload had an impact on CO 2 levels in RPDs. In addition the CO 2 values will be compared to current respirator design standards. It was anticipated that speech, gender, body size and workload (exercise intensity) would influence CO 2 concentrations within RPDs. This research will lead to a better understanding of the physiological response to respirator use .
The study was conducted in two parts: a pilot study conducted at the University of Wollongong and a field study carried out at a refinery in Mount Isa, Queensland. This report outlines the results of the field study.
Methods

Participants
The study was approved by the Human Research Ethics Committee of the University of Wollongong/South Eastern Sydney and Illawarra Area Health Service (Reference Number: HE11/437). A total of 46 participants (one female) familiar with the use of RPDs, volunteered for the field study. Before taking part, all details of the study were explained and informed written consent was obtained from participants.
Prior to participation, participants completed a Physical Activity Readiness Questionnaire (PAR-Q) which is a self administered survey that screens individual's cardiovascular disease risk factors and symptoms (PAR-Q 2002) . The State-Trait Anxiety Inventory (STAI) that assesses participants "state" and "trait" anxiety symptoms (Spielberger et al. 1983 ) was also administered. Participants were excluded if pregnant, suffering from severe illness or injury, obtained an STAI score at the ninetieth percentile or above, reported problems with claustrophobia or unable to obtain a satisfactory face fit with the RPD. In addition participants were required to be clean shaven, avoid exercise and smoking cigarettes or cigars on the day of testing.
Of this sample six participants did not meet the selection criteria for inclusion into the study, leaving a total of 40 participants (one female). The ages ranged from 19 to 58, with a mean age of 35 (SE = ±1.50). The majority of these participants were non-smokers (n=32) and 55% (n=22) reported that they were physically active or exercised on a regular basis.
Information on the participants characteristics are provided in Table 1 .
Equipment
A quantitative respirator fit test with a calibrated TSI Portacount Plus (TSI Incorporated; Shoreview, MN, USA) was performed to ensure that the RPD achieved an adequate face seal on the wearer. The TSI Portacount Plus uses a technique known as condensation nuclei counting (CNC) (TSI 2012) . This involves the measurement of the particle concentrations outside the mask and inside the mask. The ratio of these two values is the RPD fit factor.
Participants were required to obtain an overall fit factor of greater than 500 to be included in the study. This constraint was important to ensure leakage factors would not limit the results. . The unit was calibrated at regular intervals during test procedures using certified calibration gas bottles (0% CO 2 and 5% CO 2 ). A Data Acquisition (DAQ) system was connected to a personal computer (PC) and collected data with 50 samples per second rate. The DAQ system performed data monitoring (such as pressure/ flow, valve control and CO 2 management) and data storage for further analysis.
The exercise test was performed on a stationary cycle ergonometer (Monark Bodyguard AB; Varberg, Sweden). The cycle ergonometer was calibrated before the assessment dates. Participants heart rate was measured throughout the exercise test using a Polar heart rate monitor (Polar FT1, Polar Electro; Kempele, Finland). The Modified Borg Scale (MBS) was used to measure participant's subjective level of dyspnoea (breathing discomfort). The MBS is a visual analogue scale which allows participants to rate their level of breathlessness from 0 (Nothing at all) to 10 (Maximal) accessed from the Australian Lung 
Test procedures
Exercise tests were carried out in an air-conditioned room maintained at an ambient temperature of 24° C, with an average relative humidity of 40%. ). During the third minute of exercise participants read from a prepared text. Talking was discouraged during the periods before and after speech.
During minute two (no speech) and minute three (speech) of each stage gas analysis and measurement of the physiological parameters (HR, MBS, PIAF) was conducted.
All participants could voluntarily halt the assessment process at any time. The test was terminated after four stages, volitional fatigue, a rating of dyspnoea of seven or greater or when the participant reached 85% of their age-predicted maximal HR (220-age).
Immediately after exercise all participants were asked if they experienced any symptoms of CO 2 exposure, such as headache, blurred vision or dizziness. Additionally participants were allowed an active recovery period of two to five minutes (low load pedalling). The same RPD was used for each procedure. After each test the RPD was thoroughly cleaned and disinfected.
Statistical analysis
The physiological data were calculated for both breathing conditions (speech and no speech) 
Results
Of the 46 volunteers, 13% (n=6) did not meet the selection criteria for inclusion into the study. Five participants were excluded from participation at the level of the PAR-Q form and one due to equipment failure. All participants passed a quantitative respirator fit test (>500 protection factor) with a Portacount. Data for the remaining 40 participants who completed all phases of the test are presented in Table 2 .
The duration of the exercise test, including warm up varied from 8-22 minutes. Within this, 12 participants (30%) did not reach 85% of their age-predicted maximal HR. Reasons to stop the exercise test before target HR was reached included lower limb fatigue (n=6), end of exercise protocol (n=3), severe breathing discomfort or dyspnoea (n=2) and general fatigue (n=1).
Speech (phonic respiration)
The mean PICO 2 values that occurred during periods of speech and no speech for both rest and exercise are shown in Table 3 . Paired t tests were carried out to compare differences in PICO 2 between the two conditions. A significant difference in PICO 2 between periods of speech and no speech occurred at rest, 75 W, 100 W, 125 W and 150 W. Although there was a relationship at 175 W, it did not achieve significance.
In general PICO 2 levels were below 2% in periods without speech. However during speech, PICO 2 was observed to often exceed this, above all at rest. An elevation of PICO 2 above 3% (100 times atmospheric concentrations) was experienced by three participants at rest (speech). One in three participants (n=11) were exposed to PICO 2 greater than 2% during periods of work and speech (75 W, 100 W and 125 W). In the absence of speech PICO 2 concentrations were observed to decrease, especially with each increase in workload.
The lowest average PICO 2 (0.97%) occurred at a mean O 2 of 28.7 mL·kg·min -1 , no speech.
No participants reported symptoms of headache, blurred vision or dizziness.
Peak inspiratory air flow
The mean PIAF for all workloads during periods of speech and no speech is displayed in occurred at rest and during no speech.
3.3.Oxygen uptake
The mean PICO 2 levels as a function of mean O 2 during speaking and non speaking periods is displayed in Figure 3 . 
Effects of mixed expired carbon dioxide
On average PECO 2 appeared to be higher during periods without speech. The highest mean PECO 2 was 5.8% and occurred at 75 W (speech) and 100 W (no speech) . However the lowest mean PECO 2 was 2.9% and occurred at rest (speech).
Dyspnoea
Dyspnoea (MBS) scores during speech and no speech periods are shown in Table 2 . No dyspnoea was reported during resting conditions. Ratings of dyspnoea was reported to be somewhat severe (4) or higher by 92% (n=12) of participants at 150 W (speech) and 100%
(n=3) at 175 W (speech). Breathing discomfort was reported to rise during both increases in exercise effort and periods of speech. Due to the opposing effects of these variables on PICO 2 the relationship between PICO 2 and dyspnoea did not produce a significant result in this study.
3.6.
Heart rate HR was on average 2.9% higher during speech conditions than no speech at the same workload. Therefore speech appears to increase the work of breathing (energy expenditure).
This effect appeared to decrease as workload increased (175 W excluded).
Breathing frequency
Overall, there was a reduction in mean during speech. During speech decreased by 23.5% at rest. However progressive increases in exercise workloads caused participants to speak fewer words from the text and gradually increased. Consequently during speech and non speech periods at 175 W (peak exercise) was comparable.
Discussion
Increased levels of CO 2 rebreathing in RPDs can have a profound effect on the respiratory system and is a concern regarding respirator use (ISO/TS 16976-3: 2011). A literature review by NIOSH (1976) indicates 1% inspired CO 2 is associated with respiratory stimulation such as increased , alveolar CO 2 and O 2 . This current study demonstrates that periods of speech in RPDs cause an increase in inspired CO 2 well above the normal concentration found in atmospheric air (0.03%) (Williams 2010) . Almost one in three participants inspired CO 2 concentrations 2% or higher during periods of speech at sedentary to low work rates. These findings suggest prolonged speech can contribute to CO 2 surpassing current respirator design standards that specify inspired CO 2 should not exceed 1% for more than one consecutive ) while wearing the RPD. Data collected showed that dead-space CO 2 ranged from 2.5-3.5% CO 2 which is significantly above OSHA's ambient workplace standards. Roberge et al. (2010) concluded that even though the RPD did not impose any significant physiological burden on participants, CO 2 retention was a possibility due to elevated transcutaneous CO 2 (equivalent to arterial CO 2 ) levels. On a similar note, although no symptoms of CO 2 retention were recorded in this study, the increases in CO 2 during speech were sufficient enough to impact the participant.
There has also been concern that exercise compounds CO 2 rebreathing in RPDs due to increased metabolic CO 2 production (Williams 2010 ). In the current study PICO 2 was shown to be inversely related to exercise. This demonstrated that the large full face S.E.A Pty Ltd
Respirator was efficient in the removal of dead space CO 2 at higher work rates. These findings support research conducted by Kloos and Lamonica (1966) and Luria et al. (2004) who found low work rates during RPD use was associated with CO 2 accumulation. A previous study by Luria et al. (2004) attributed this to a rise in ventilation and lower dead space during higher exercise efforts.
We also noted that breathing frequency and positive pressure in the mask decreased each time speech was added. This also suggests speech produces a reduction alveolar respiration without a change in metabolic rate which tends to increase CO 2 concentrations in RPDs (ISO/TS 16976-3:2011 Love et al. (1979) and Takahashi et al. (2000) found when CO 2 was added to inspired air all participants increased their respiration but the degree of this response varied considerably.
There was a small increase in HR noted during speech. These effects demonstrate that there is an increase in physical exertion during speech and RPD use. Therefore speech may limit physical performance while wearing RPDs.
In this study, the process of speaking and exercise was enough to cause symptoms of breathing discomfort. Therefore the present study could not attribute any physiological symptoms of dyspnoea to CO 2 rebreathing.
Also, participants were more likely to pause from speaking at higher workloads due to the breathing requirements required for exercise. This would improve oxygen delivery to the participant wearing the RPD and decrease the level of CO 2 rebreathing. This can potential confound the results.
It is also important to note exercise intensities in this study were only set at low to moderate workloads. Therefore differences in PICO2 during maximal exercise, where CO 2 production can exceed 4 L·min -1
(ISO 16976-3: 2010) cannot be compared and limits the interpretation of these results.
A further limitation of the study was the underrepresentation of women and smallmedium body surface area (BSA) groups. Differences in gender and BSA might influence CO 2 production and sensitivity to CO 2 exposure. Future research could overcome this by analysing women and different BSA groups separately.
Conclusion
Overall, the results of the study indicate speech and low work rates significantly increase CO 2 rebreathing in RPDs. Based on Australian respirator design standards it is evident speech could contribute to inspired CO 2 exceeding the maximal allowable concentrations in inspired air. However, the impact of gender and body size on CO 2 levels could not be ascertained.
The implication of these findings is that high CO 2 concentrations in full face RPDs may be linked to wearer discomfort and contribute to reduced tolerability and wear time of the device. Since many occupations require workers to communicate while wearing RPDs these findings must be taken into consideration. It is recommended that the findings in this study be considered in the design and use of RPDs.  Table 1 . Characteristics of the field study participants  Table 2 . Effects of speech on respiratory parameters during rest and exercise wearing a full face respiratory protective device  Table 3 . Mean carbon dioxide inspired at rest and exercise for conditions of no speech and speech  Table 4 
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